Sara Manrique‐Arija

Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study

José L. Pablos, María Galindo-Izquierdo, Loreto Carmona et al. · Annals of the Rheumatic Diseases · 2020 · 238 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12

Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases

José L. Pablos, Lydia Abásolo, José María Álvaro‐Gracia et al. · Annals of the Rheumatic Diseases · 2020 · 146 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +14

Efficacy of Tocilizumab in Conventional Treatment–Refractory Adult‐Onset Still's Disease: Multicenter Retrospective Open‐Label Study of Thirty‐Four Patients

F. Ortíz-Sanjuán, Ricardo Blanco, V. Calvo-Río et al. · Arthritis & Rheumatology · 2014 · 143 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +10

Multicenter longitudinal study of B-lymphocyte depletion in refractory systemic lupus erythematosus: the LESIMAB study

Antonio Fernández‐Nebro, JL Marenco de la Fuente, Luis Carreño et al. · Lupus · 2012 · 115 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice

Monica Calderón-Goercke, J. Loricera, Vicente Aldasoro et al. · Seminars in Arthritis and Rheumatism · 2019 · 109 citations · Full text

Life Sciences, Pharmacotherapy, Surgery +6